{
  "image_filename": "table_p7_det_6_000.png",
  "image_path": "Grohskopf_et_al.__2023_/extracted/figures/table_p7_det_6_000.png",
  "image_type": "Table",
  "page_number": 7,
  "block_id": "det_6_000",
  "claim_id": "claim_003",
  "claim": "Recombinant technology leads to a broader immune response that may provide cross-protection, even in a mismatch season.",
  "supports_claim": false,
  "explanation": "A table listing contraindications and precautions for different types of influenza vaccines (egg-based IIV and LAIV, cell culture\u2013based IIV, and recombinant influenza vaccine) according to ACIP guidelines, with footnotes defining abbreviations. does not support the claim because the table only provides information on contraindications and precautions for various influenza vaccine types and contains no data on immune response breadth or cross-protection in mismatch seasons.",
  "model_used": "o4-mini",
  "detailed_analysis": {
    "supports_claim": false,
    "image_description": "A table listing contraindications and precautions for different types of influenza vaccines (egg-based IIV and LAIV, cell culture\u2013based IIV, and recombinant influenza vaccine) according to ACIP guidelines, with footnotes defining abbreviations.",
    "evidence_found": null,
    "reasoning": "does not support the claim because the table only provides information on contraindications and precautions for various influenza vaccine types and contains no data on immune response breadth or cross-protection in mismatch seasons.",
    "confidence_notes": null
  }
}